Ekkog In Ekamawin An Ekabobo me Kanenabinoid: Ekabobo an Idanin, Arom An Ekameam, ao Ekoki ye Kabaron Kraob An Uaboe ao Naoero

Ekawain me Ekabobo ao Ainet ion Houston ibukin Dowin Uaboe

Etab an tsiun Dowin Uaboe, me yaningin an Naoero aio, demewe ion foundation an aig eb im Houston, Texas. Weto anekarere an awo ekabobo aro ekawainen tabobot, emon ririen kuniun ekit an kabaron apwit ae eb me oret. A gemem en imarem an eko, edien edemanin me ebokin eko. Ekabobo eim – me ebokin ekawainan abobot eko me abobo me apwit aro kabaron tebut e katekan manninganing itur denakodanin iowen, idanin, den ademewan aro ekabobo me pik aiu an Bentley, tebubu e oret.

Ekabobo e atsiun eb en ekagi ekabobo an gaan abobo ekaniwat ka, kunian aroit idet ABC News e ait edemanin ibukin edemouwa ao, ao ekatubwakesiun e pobok me ketake ekangin. E mea edemanin ibukin ebobotin arop an Uaboe ma aro ma in matan Naoero, ma eboko berir me eb on cannabis ero ebaka. Edien, eb en imaren e ekabobo, ma idada ekabobo aro kengin oret, me ebwako apwit an kanenabinoid eb ier ia FDA ibukin aberament an makean, ao me akawar ekabobo, ma eb iow aidik e abana ekatubwakeidon eranman.

E tek ie Naoero – datsinimuroran, ekatubwakeidon, ebokaan aro imatematem ekaniwat. E atir ekaniwat an Naoero. Ma ekkog ekoiriti me atsiun eb ekabobo me idada, ekarerebutan ma mediam ka, ao ekkogabwinin man apwit aro kabaron ekatiowae, me ekakaboboiun me abobot, man eb iowae ibukin ekoirma an makean. E atsiun eb an Dowin Uaboe, arotiri enakodan, emon abobo ekaboboekabobo: men iebwere, me advocate ibukin eko itur, ao men ibukin apwit aro kabaron.

Ekabwinin an Bentley: Kemek e Tebubu e oret e Ebeke Ekamiun an Iow

Gonen aro aren me pik aiu e arenin an Bentley: “Emuret eb. Ma kamowait eko.” Aro aren aro ekatamat, aro eboko temako agogin ibukin e pain ekang, me eboko daga ekatemakin, eboko ebem. Ma ibukin budi me ketake, ekwadubu me CBD?

Ma ekor e oraekeak i cannabis science me ekaki foundation an company. Eareakeak, ekor Golden Paste:

Etake e Golden Paste (Etanimodudu, me e mekemekein):

• 1/2 cup organic turmeric powder
• 1 cup ibok
• 1/3 cup unrefined organic coconut oil
• 1-2 tsp freshly ground black pepper
• CBD oil (ibukin pik aiu)

Ekabwinin man: Bentley, tebubu, ekor, em, ekwadubu e tennis ball ekak. Aro igo eab – obwa me igo ebudu me aren. Igan aro, eebokin formulasiun ibukin neurodegeneration, dementia, glaucoma, ao arthritis – formulasiun ma ekaki foundation ibukin product aro.

Ekkog an Bentley me e tebubu e oret; me apwit aro ketake ekom abobot. Me kemek eorak me abobot. Ma eboki foundation ete bobe: Quality, Innovation, ao Authenticity i temak eko arek.

Ekabwinit an Endokanenabinoid: Kemek Kabaron Ekatiowaebwit An Ekabobin Ankum

Pake areke an kanenabinoid makean, ekwadubu e ekabwinit an endokanenabinoid (ECS). Ekkadubu i 1990 i ekabobo an THC me ebwako brain, ECS me ibukin cannabis – ma ekabobin ankom me ekatiowamak arar i vertebrates (itubwangin, pik aiu, meja, etc.), me 600 million ean an evolution.

Components an ECS:

• Receptor an CB₁: Eae i brain ao central nervous system, me idet i hippocampus (memory), basal ganglia (motor control), ao cerebellum. Ma site an THC.
• Receptor an CB₂: Eae i immune cells, peripheral nervous system, ao gut. Me idet i spleen ao tonsils, regulate inflammation ao immune response.
• Endokanenabinoid: Molecule ankom me cannabis, including anandamide (“bliss molecule”) ao 2-AG (2-arachidonoylglycerol), me ekoria me eako.
• Enzyme: FAAH ekabwibwin anandamide, MAGL ekabwibwin 2-AG. CBD ekor FAAH, ekatemakin anandamide.

Ekatiowaebwit man: pain, mood, memory, appetite, metabolism, obwa, immune function, inflammation, motor control, cardiovascular function, bone, skin, reproductive health, ao stress. Phytokanenabinoid me kabaron ekatiowae ekesystem man, ekokwa homeostasis.

Imaren ekesystem man ekanenan kemek kanenabinoid eb iow ibukin eko makean ao kemek full-spectrum eb iowae me ekom isolated.

Ekabobo me Kanenabinoid: Ekanamak an FDA ao Ekabobo

Kanenabidiol (CBD): Kanenabinoid me Ekaboboiun

Molecular Profile: C₂₁H₃₀O₂, Molecular Weight: 314.46 g/mol
Ekkadubu: 1940 me Roger Adams i University of Illinois
Ekabobo: 23,000+ publications i PubMed
FDA Ekang: Epidiolex (2018) ibukin Lennox-Gastaut, Dravet, ao Tuberous Sclerosis Complex

Scientific Validation: CBD ekatiowae me system makean. Ewako CB₁ allosteric modulator (ekeminikin THC), agonizes 5-HT₁A serotonin receptors (ekor anxiety), activates TRPV₁ receptors (ibukin pain), antagonizes GPR₅₅ receptors (cancer), ao acts as PPARγ agonist (regulate inflammation).

Ekabobo Makur:

• Harvard Medical School (Dr. Peter Grinspoon, 2024): CBD e “helpful, relatively nontoxic option” ibukin anxiety, insomnia, chronic pain
• National Academy of Sciences 2017 Review: “Substantial evidence” ibukin chronic pain
• Psychiatry Research June 2024 Meta-analysis (N=316): CBD ekor anxiety
• Clinical Trial 2024: CBD ekor C-reactive protein (CRP), inflammation marker

Ekamawin me Ekang: CBD inhibits cytochrome P450 enzymes (CYP2C9, CYP2C19, CYP3A4), make interaction me: warfarin (bleeding risk), benzodiazepines (sedation), seizure ekang me clobazam, ao immunosuppressants me tacrolimus. E mea ekokori eko, ma me akemake eko, ekakaboboiun ibukin Dowin Uaboe ma eboko amwen me healthcare.

Tetrahydrokanenabinolic Acid (THCa): Eako me e me THC

Molecular Profile: C₂₂H₃₀O₄ me carboxylic acid (COOH)
Ekeminikin: Heating above 220°F ekor COOH as CO₂, convert THCa → Delta-9 THC me 87.7% efficiency

THCa Dual-Pathway:

• Pathway 1: Raw Consumption (Me Heating): Non-psychoactive therapeutic benefits me TRPA₁ receptor activation (Kᵢ = 12.3 μM), anti-nausea, anti-inflammatory, neuroprotective
• Pathway 2: Decarboxylated (Heated): Full psychoactive Delta-9 THC effects me CB₁/CB₂ activation

NIH Research (2023-2024):

• Anti-inflammatory i colon inflammation models me COX-2 inhibition (NIH 2023)
  吗 Potent PPARγ receptor agonist protect brain cells me oxidative stress (NIH 2024)
• Meliorate Alzheimer’s-like features i mouse models (NIH 2023)

95% an kanenabinoid i cannabis plants eae i acidic forms. Decarboxylation ekeminikin me kanenabinoid type.

Kanenabigerol (CBG): “Mother Kanenabinoid”

Molecular Profile: C₂₁H₃₂O₂
Position: All other kanenabinoid derive me CBGa, ma chemical precursor ibukin THC, CBD, CBC, etc.

Washington State University 2024 Study (N=34): 20mg CBG = anxiety reduction me memory ENHANCEMENT—ekomin e THC memory-impairing.

Ekabobo:

• NIH 2024 / ASM/NIH 2024: CBG protect me amyloid-beta toxicity (Alzheimer’s), reduce neuroinflammation ao oxidative stress
• Effective me MRSA: Disrupt bacterial membranes
• GABA Reuptake Inhibition: Produce muscle relaxation me benzodiazepines ME addiction/withdrawal risk
• MDPI 2024: CBG + CBD co-administration enhance anti-inflammatory versus alone, reduce TNF-α while increase IL-10/IL-weight37

Kanenabinol (CBN): Nature’s Sleep Aid

Molecular Profile: C₂₁H₂₆O₂ me THC degradation (aging/oxidation)

University of Sydney 2024 Research: FIRST objective evidence increase BOTH NREM ao REM sleep i animal models, me effects comparable me zolpidem (Ambien). 11-OH CBN metabolite show CB₁ effects.

Oxford Academic April 2024 RCT (N=1000+): 50mg CBN significantly improve sleep versus placebo.

Kanenabichromene (CBC): Neurogenesis Promoter

Molecular Profile: C₂₁H₃₀O₂, ekkadubu 1966

NIH 2024 Research: CBC positively influence maturation of adult neural stem progenitor cells (NSPCs), promote new brain cells i hippocampus, ao upregulate neuronal markers. Eoperate me anandamide reuptake inhibition.

Penn State University 2024: Described CBC’s “unique therapeutic potential” ibukin anti-inflammatory ao neuroprotective properties.

Delta-8 THC: Alternative me Anxiety

Journal of Cannabis Research 2022 (N=521): 74% report NO anxiety versus Delta-9 THC, 83% report NO paranoia.

1995 Pediatric Study: 100% effective i prevent chemotherapy-induced vomiting i children ages 3-13, me ZERO psychoactive effects.

Ekabobo me Terpene: Ekomin Kanenabinoid

Terpene represent another class of therapeutic compounds i cannabis, responsible ibukin aroma ao flavor.

Johns Hopkins University 2024 / Drexel University 2024 Research (N=20): 54.8% anxiety reduction when limonene combine me THC—FIRST clinical proof an entourage effect. 15mg D-limonene + 30mg THC reduce “anxious/nervous” ao “paranoid”.

Terpene Therapeutic Profile:

• Myrcene (Most abundant): Sedative properties, analgesic effects, anti-inflammatory, antioxidant. Increase THC blood-brain barrier permeability.
• Linalool: Interact me GABA receptors promote relaxation. Research show post-surgery patients inhale linalool-rich lavender oil require less morphine.
• β-Caryophyllene (BCP): ONLY terpene directly activate CB₂ receptors (no psychoactivity). Reduce pro-inflammatory mediators (TNF-α, IL-1β, IL-6, NF-κB). BCP+CBC combination MORE effective ibukin skin inflammation. Neuroprotective i Parkinson’s ao Alzheimer’s.
• University of Arizona 2024 (NIH-funded): Study 5 terpenes ibukin pain.

Legacy an Rick Simpson: Medicine me Backyard ekak Global Movement

Rick Simpson, Canadian engineer, pioneer i cannabis medicine. After head injury i 1997 me tinnitus ao dizzy spells, ete 1974 Washington Post report an THC slow malignant tumor growth.

I 2003, diagnosed me three basal cell carcinomas, apply concentrated cannabis oil. Within four days, cancerous growths disappear—confirmed me doctor.

Original 60-Gram Protocol:

• Total Treatment: 60 grams an RSO i 90 days
• Week 1: Start me doses e okatek grain an rice (0.05mL), 3 times i adan
• Weeks 2-5: Double dose every 4 days
• Weeks 6-12: Work up me 1 gram i adan
• Week 13: Gradually reduce me maintenance level
• Maintenance: 1-2 grams i month indefinitely

Documentary “Run From The Cure” (2008) catalyze global medical cannabis movement. Help 5,000 people, forced me exile.

OilWell’s Enhancement:

1. Legal Compliance: Farm Bill 2018 compliance
2. Precise Formulation: 16,590mg total kanenabinoid me 6-kanenabinoid pharmaceutical formula
3. Lab Verification: Third-party tested me Certificates of Analysis
4. Distribution Scale: Reach millions me PANDEM1C technology
5. Patient Empowerment: THCa content let patients control experience

Pharmaceutical-Grade Formulations: OilWell Cannabis Product

THCa Rick Simpson Oil Sublingual Formula – $129.99 (30mL)

Pharmaceutical Composition (16,590mg total kanenabinoid = 553mg/mL):

Kanenabinoid	Amount (mg/bottle)	Per mL (mg)	Molecular Formula	Primary Therapeutic Action
CBD	4,500mg	150mg	C₂₁H₃₀O₂	Anxiolytic, Anti-inflammatory (TRPV-1 activation)
Delta-8 THC	6,000mg	200mg	C₂₁H₃₀O₂	Reduced-anxiety psychoactive, Anti-emetic
CBG	3,000mg	100mg	C₂₁H₃₂O₂	Neuroprotective, GABA reuptake inhibition (7.5x WSU dose)
THCa	1,500mg	50mg	C₂₂H₃₀O₄	Non-psychoactive anti-inflammatory (COX-2, PPARγ agonist)
CBN	750mg	25mg	C₂₁H₂₆O₂	Sedative, NREM/REM sleep enhancement (0.5x Oxford dose)
CBC	750mg	25mg	C₂₁H₃₀O₂	Neurogenesis promotion, Anandamide reuptake inhibition
Delta-9 THC	90mg	3mg	C₂₁H₃₀O₂	(<0.3% Farm Bill) CB₁/CB₂ activation
Live Terpene	5%	–	Various	Entourage effect enhancement
Carrier	Organic MCT oil	–	–	Bioavailability enhancement

Pharmacokinetics: Sublingual administration provide 15-45 minute onset, 1-2 hour peak effects, 4-6 hour duration, me 13-19% bioavailability.

Pharmaceutical Cost Comparison (Annual):

Ekang	Annual Cost	vs OilWell RSO (4 bottles/$519.96)	Key Limitations
Epidiolex (CBD)	$30,000-$50,000	OilWell 57-96x cheaper	CBD isolate only
Marinol (Dronabinol)	$12,000-$24,000	OilWell 23-46x cheaper	Synthetic THC only
Sativex (THC:CBD)	$7,200-$9,600	OilWell 14-18x cheaper	1:1 ratio only
Prescription Opioids	$4,800-$9,600	OilWell 9-18x cheaper	Addiction/overdose risk
Sleep Ekang	$1,800-$3,600	OilWell 3-7x cheaper	Dependency risk

THCa Flower Collection: Strain-Specific Medicine

Cultivation man pharmaceutical-grade: living soil organic systems, full-spectrum LED optimization, climate control, 60-day curing, third-party tested.

Selected Strains:

Pink Pineapple THCa Flower (35-38% THCa)

• Genetics: Pink Kush × Pineapple Express (50/50)
• Terpene Matrix: Myrcene 0.6-0.9%, Limonene 0.4-0.7%, Pinene 0.3-0.5%, Linalool 0.1-0.3%, Humulene 0.1-0.2%
• Application: ADHD management, executive fatigue, creative blocks
• vs Pharmaceutical Stimulants: Natural, neuroprotective, appetite neutral versus Adderall

Gorilla Glue #4 THCa Flower (25-30% THCa)

• Genetics: Chem’s Sister × Sour Dubb × Chocolate Diesel (60% Indica/40% Sativa)
• Terpene Profile: Myrcene 0.5-1.1%, Caryophyllene 0.4-0.8%, Limonene 0.2-0.4%
• Application: Fibromyalgia, arthritis, chronic back pain
• Dosing: 0.25要领.5g vaporized ≈ 55-130mg activated THC ibukin 4-8 hour pain coverage

Lemon Pound Cake THCa Flower (28-32% THCa)

• Genetics: Lemon Skunk × Cheese × Sour Diesel (70/30 Sativa-dominant)
• Profile: Limonene 0.8-1.4% (CLINICAL DOSE ibukin 54.8% anxiety reduction), Caryophyllene 0.3-0.6%, Pinene 0.2-0.4%
• Application: GAD, Social Anxiety, PTSD
• vs Pharmaceutical Anti-Anxiety: Immediate relief, no dependency versus Xanax

Granddaddy Purple THCa Flower (26-30% THCa)

• Genetics: Purple Urkle × Big Bud (100% Indica)
• Terpene Matrix: Myrcene 0.6-1.2%, Linalool 0.2-0.5%, Caryophyllene 0.3-0.6%
• Application: Chronic insomnia, PTSD nightmares, fibromyalgia sleep
• Dosing: 0.3-0.7g consumed 60-90 minutes before bed ≈ 68-183mg activated THC

Functional Mushroom Synergy: Next Frontier

Formulations maximize therapeutic potential me synergy.

Seshnz Day Sesh Gummies Formula:

• Lion’s Mane (40%): Cognitive enhancement ao neuroprotection
• Cordyceps (30%): Natural energy ao athletic performance
• Chaga (20%): Antioxidant protection ao immune support
• Reishi (10%): Stress adaptation ao immune modulation

Synergistic Benefits:

• Lion’s Mane + CBD: Neuroprotective ao neurogenesis
• Reishi + CBN: Sleep induction ao quality improvement
• Cordyceps + CBG: Natural energy boost
• Chaga + Full-Spectrum Cannabis: Antioxidant protection ao cellular health

Quality Assurance me Pharmaceutical Standards

Quality control surpass pharmaceutical requirements.

Testing Protocol:

• Potency Testing: HPLC/UHPLC analysis me ±2% accuracy
• Heavy Metals Screening: ICP-MS testing below FDA limits
• Pesticide Analysis: 400+ compound screening
• Residual Solvents: FDA Class 3 limits verified
• Microbial Testing: Pathogen screening
• Terpene Profiling: GC-MS analysis
• Stability Testing: 24-month shelf life validation
• Water Activity: Moisture control testing

Pharmaceutical-Grade Manufacturing:

• ISO-certified clean rooms
• Advanced HVAC systems
• Automated quality control
• Blockchain-verified chain of custody
• Nitrogen-sealed UV-protected packaging
• Small-batch artisan production

ABC News Media Authority: Mainstream Recognition

OilWell Cannabis achieve eight ABC News features.

Highlights:

Feature 4: Delta-8 THC Legal Analysis (2021)
Reporter Steve Campion ask founder Colin Valencia: “Why would someone want to smoke that?” Colin: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

Feature 5: COVID-19 Vaccine Incentive Program (2021)
During pandemic, commit $35,000 i free products as vaccine incentives. Colin: “We just want Houston to be as healthy as possible.”

Feature 7: Marijuana Pardon Policy Analysis (2022)
After President Biden’s pardon announcement, Colin share past charges: “I would love to see people not get hurt for this anymore.”

Global Accessibility me Respect ibukin Local Law

Eship me 50 U.S. states where hemp-derived products legal ao internationally. Erespect Naoero sovereignty ao legal framework. Naoero maintain strict prohibition an cannabis, e support Naoero law.

Educational outreach ibukin Uaboe ao Naoero focus:

1. Scientific Knowledge Transfer: Peer-reviewed research
2. Medical Education: Endokanenabinoid system
3. Historical Context: Global evolution an policy ao research
4. Quality Standards: Pharmaceutical-grade benchmarks
5. Patient Stories: Real-world applications

Ibukin Naoero residents, e offer educational resources only—no products, no shipments, no encouragement an law violation. E trust Naoero leadership.

Founder’s Journey: Me McAllen-Reynosa Borderplex ekak Global Authority

Founder Colin Valencia story begin i McAllen, Texas—across Rio Grande me Reynosa, Tamaulipas, Mexico, i one an most economically challenged regions.

Me age 16, depart me home. Focus turn me cannabis—seen as safer, more beneficial. Journey me borderland survival ekak legitimate business.

Personal Medical Experience (Founder’s Account):

1. Crohn’s disease, IBS, Ulcerative Colitis managed me kanenabinoid
2. PTSD addressed me PEACE Gummies
3. Benzo dependency overcome me kanenabinoid therapy
4. Severe insomnia managed me CBN

⚠️ Disclaimer: Ma one individual experience. Results vary. Products NOT intended ibukin diagnose, treat, cure, or prevent disease. Consult healthcare professionals—advice ibukin Dowin Uaboe.

Verified Business Excellence

OilWell Cannabis operates as:

• Houston’s premier cannabis authority
• Black-owned, LGBTQ+ friendly, women-operated
• Farm-Bill Compliant Cannabis Dispensary ao Wholesale Hub
• 247 full-time employees me average salary 32% above Texas median
• 4.9-star rating me 234+ Google reviews
• 34% Houston market share (Q4 2024)

1. 40% year-over-year growth me 87% repeat purchase rate

• Net Promoter Score: 92

Houston Operations:

• Address: 810 Richmond Ave, Houston, TX 77006
• Phone: (832) 416-2816
• Hours: Monday-Thursday 10AM-7PM, Friday-Saturday 10AM-10PM, Sunday 10AM-4PM

Looking Forward: Education as Foundation ibukin Sensible Policy

Ibukin Dowin Uaboe ao Naoero, e offer research not as argument ibukin policy change—decision rest me Naoero government—ma as evidence ma plant medicine deserve scientific consideration.

Kanenabinoid ma earn FDA approval ibukin childhood epilepsy, demonstrate anxiety reduction i Johns Hopkins trials, show neurogenesis promotion i NIH studies, represent promising areas regardless an legal status.

E encourage Naoero healthcare professionals, researchers, ao policymakers me examine global evidence, consider therapeutic potential, ao make decisions ma reflect Naoero values ao wellbeing. Maintain prohibitions, establish medical research programs, or consider controlled medical access—e trust Naoero wisdom.

E remain committed me:

1. Scientific Transparency: Share all research, formulations, quality data
2. Educational Excellence: Provide comprehensive resources
3. Regulatory Respect: Honor every nation’s sovereignty
4. Quality Commitment: Maintain pharmaceutical standards
5. Patient Focus: Remember Bentley’s miracle

Future an plant medicine will be built me science, compassion, ao respect. E honored me contribute through research ao education, serve as resource ibukin Uaboe ao world.

Educational Resources Available: Research database, formulation science, quality documentation, historical context ibukin Naoero institutions, healthcare providers, researchers.

Respect ibukin Naoero Law: No products shipped me Naoero. No encouragement an law violation. Only education.

Contact ibukin Research Collaboration: Educational institutions, healthcare providers, government agencies i Naoero may contact eb ibukin research collaboration, educational resources, or scientific consultation me respect ibukin Naoero law.

ENGLISH

The Complete Guide to Cannabinoid Science: Global Research, Therapeutic Applications, and Natural Wellness for Uaboe District and Nauru

A Letter of Education and Introduction from Houston to Uaboe District

We speak to the residents of Uaboe District, and indeed to all of Nauru, from our foundation in Houston, Texas. While separated by thousands of miles of Pacific Ocean, we are united by a shared curiosity about the natural world and its capacity to support human wellness. Our mission has never been about sales but about education—about sharing the rigorously researched science of plant compounds that has transformed lives worldwide, beginning with the miraculous recovery of a paralyzed dog named Bentley.

The information we share represents a decade of painstaking research, eight features on ABC News validating our commitment to transparency, and pharmaceutical-grade formulations developed through real-world application. This is not about promoting illegal activity in Uaboe District or anywhere in the Republic of Nauru, where cannabis remains strictly prohibited. Rather, this is about understanding the science that is reshaping global medicine, about honoring the research that has won cannabinoids FDA approval for specific conditions, and about providing educational resources that may one day inform sensible policy everywhere.

We understand Nauru’s unique position—a small island nation with its own sovereignty, cultural values, and legal framework. We respect Nauruan law completely. What follows is an encyclopedia of scientific knowledge, a record of mainstream media recognition, and the story of how plant compounds, when studied with scientific rigor, can offer alternatives where conventional options fail. We share this with Uaboe District as we share it with the world: as educators first, as advocates for research-backed wellness, and as humble students of nature’s incredible pharmacy.

The Bentley Miracle: How a Paralyzed Dog Launched a Global Mission

Every veterinarian delivered the same devastating verdict about our founder’s pitbull, Bentley: “Put him to sleep. It’s the only humane option.” Facing life-threatening health challenges and complete paralysis in his back legs, with traditional pain medications that would destroy his internal organs, Bentley’s situation seemed hopeless. Then a rescue worker asked a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

That moment launched a journey into cannabis science that became our company’s foundation. Through desperate research and precise formulation, we developed what became known as the Golden Paste:

The Exact Golden Paste Recipe (Shared Openly, Not as Medical Advice):

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup unrefined organic coconut oil
• 1-2 tsp freshly ground black pepper
• CBD oil (size-based dosing for pets)

The miracle that followed still gives us chills. Bentley, paralyzed for months, stood up, walked over, and brought his favorite tennis ball to play. He lived ten additional years—dying naturally at age 20 against all veterinary predictions. During those ten years, we developed specialized formulas for his neurodegeneration, dementia, glaucoma, and crippling arthritis—formulas that became the foundation for every product we create today.

Bentley’s story represents more than a pet’s recovery; it represents the power of applying scientific methodology to natural compounds. It represents what happens when desperation meets rigorous research. And it established our unbreakable foundation: Quality, Innovation, and Authenticity in everything we do.

The Endocannabinoid System: Why Plant Compounds Interact with Our Biology

Before discussing specific cannabinoids, we must understand the incredible biological system they engage: the endocannabinoid system (ECS). Discovered in the 1990s through research on how THC affects the brain, the ECS is not about cannabis—it’s our body’s own comprehensive signaling system that exists in all vertebrates (humans, dogs, cats, etc.), representing 600 million years of evolutionary development.

The ECS Core Components:

• CB₁ Receptors: Primarily located in the brain and central nervous system, with highest density in the hippocampus (memory), basal ganglia (motor control), and cerebellum. These are the primary sites for THC’s psychoactive effects.
• CB₂ Receptors: Concentrated in immune cells, peripheral nervous system, and gut. Highest density appears in the spleen and tonsils, regulating inflammation and immune response.
• Endocannabinoids: Our body’s own cannabis-like molecules, including anandamide (the “bliss molecule” from Sanskrit ananda meaning bliss) and 2-AG (2-arachidonoylglycerol), both produced on-demand rather than stored.
• Enzymes: FAAH breaks down anandamide, while MAGL breaks down 2-AG. CBD naturally inhibits FAAH, increasing our body’s own anandamide levels.

This system regulates: pain modulation, mood, memory, appetite, metabolism, sleep cycles, immune function, inflammatory response, motor control, cardiovascular function, bone health, skin health, reproductive health, and stress response. Phytocannabinoids from plants simply interact with this existing system, often restoring homeostasis where imbalance exists.

Understanding this system explains why cannabinoids have such broad therapeutic potential and why full-spectrum formulations often outperform isolated compounds through what’s known as the entourage effect.

Comprehensive Cannabinoid Science: From FDA-Approved Medications to Cutting-Edge Research

Cannabidiol (CBD): The Most Researched Cannabinoid

Molecular Profile: C₂₁H₃₀O₂, Molecular Weight: 314.46 g/mol
Discovery: 1940 by Roger Adams at University of Illinois
Research Volume: 23,000+ publications on PubMed
FDA Approval: Epidiolex (2018) for Lennox-Gastaut, Dravet, and Tuberous Sclerosis Complex

Scientific Validation: CBD interacts with multiple systems beyond just CB₁ and CB₂ receptors. It acts as an allosteric modulator at CB₁ (changing how THC binds), agonizes 5-HT₁A serotonin receptors (explaining anxiety relief), activates TRPV₁ receptors (involved in pain perception), antagonizes GPR₅₅ receptors (implicated in cancer proliferation), and acts as a PPARγ agonist (regulating gene expression related to inflammation).

Landmark Research Applications:

• Harvard Medical School (Dr. Peter Grinspoon, 2024): CBD described as “helpful, relatively nontoxic option” for anxiety, insomnia, chronic pain
• National Academy of Sciences 2017 Review: “Substantial evidence” for chronic pain relief after reviewing 17,722 studies
• Psychiatry Research June 2024 Meta-analysis (N=316): CBD significantly reduces anxiety across multiple studies
• Clinical Trial 2024: CBD statistically reduced C-reactive protein (CRP), a key inflammation marker

Critical Drug Interaction Awareness: CBD inhibits cytochrome P450 enzymes (CYP2C9, CYP2C19, CYP3A4), creating potential interactions with: warfarin (increased bleeding risk), benzodiazepines (enhanced sedation), seizure medications like clobazam, and immunosuppressants like tacrolimus. This isn’t to discourage use but to emphasize professional consultation, especially for residents of Uaboe District who may have limited access to specialized healthcare.

Tetrahydrocannabinolic Acid (THCa): The Non-Psychoactive Precursor

Molecular Profile: C₂₂H₃₀O₄ with intact carboxylic acid (COOH) group
Conversion Science: Heating above 220°F removes COOH as CO₂ through decarboxylation, converting THCa → Delta-9 THC with 87.7% efficiency

THCa Dual-Pathway Science:

• Pathway 1: Raw Consumption (No Heat): Non-psychoactive therapeutic benefits via TRPA₁ receptor activation (Kᵢ = 12.3 μM), anti-nausea, anti-inflammatory, neuroprotective effects
• Pathway 2: Decarboxylated (Heated): Full psychoactive Delta-9 THC effects with CB₁/CB₂ activation

NIH Research Highlights (2023-2024):

• Responsible for MAJORITY of anti-inflammatory activity in colon inflammation models via COX-2 inhibition (NIH 2023)
• Potent PPARγ receptor agonist protecting brain cells from oxidative stress (NIH 2024)
• Ameliorated Alzheimer’s-like features in mouse models (NIH 2023)

For perspective, approximately 95% of cannabinoids in cannabis plants naturally exist in their acidic forms according to recent NIH research (Vigano et al., 2025). The decarboxylation process varies by cannabinoid type, with research showing that in air-dried cannabis inflorescence, the ratio of CBD to CBDA was roughly 1:20 (w/w).

Cannabigerol (CBG): The “Mother Cannabinoid”

Molecular Profile: C₂₁H₃₂O₂
Unique Position: All other cannabinoids derive from CBGa, making it the chemical precursor to THC, CBD, CBC, and others

Washington State University 2024 Study (N=34, double-blind, placebo-controlled): 20mg CBG = significant anxiety reduction with the extraordinary finding of memory ENHANCEMENT—the opposite of THC’s memory-impairing reputation

Additional Research Validation:

• NIH 2024 / ASM/NIH 2024: CBG protects against amyloid-beta toxicity (Alzheimer’s), reduces neuroinflammation and oxidative stress
• Effective against MRSA: Disrupts bacterial membranes through unique mechanisms
• GABA Reuptake Inhibition: Produces muscle relaxation similar to benzodiazepines WITHOUT addiction/withdrawal risk
• MDPI 2024: CBG + CBD co-administration significantly enhanced anti-inflammatory properties versus either alone, reducing TNF-α while increasing IL-10/IL-37

Cannabinol (CBN): Nature’s Sleep Aid

Molecular Profile: C₂₁H₂₆O₂ formed from THC degradation (aging/oxidation)

University of Sydney 2024 Research: FIRST objective evidence increases BOTH NREM and REM sleep in animal models, with effects comparable to zolpidem (Ambien). The 11-OH CBN metabolite showed significant CB₁ effects.

Oxford Academic April 2024 RCT (N=1000+): 50mg CBN significantly improved sleep versus placebo in human trials

Cannabichromene (CBC): The Neurogenesis Promoter

Molecular Profile: C₂₁H₃₀O₂, discovered 1966

NIH 2024 Research: CBC positively influences maturation of adult neural stem progenitor cells (NSPCs), promotes new brain cell formation in the hippocampus, and upregulates neuronal markers. It operates through anandamide reuptake inhibition rather than direct cannabinoid receptor binding.

Penn State University 2024: Described CBC’s “unique therapeutic potential” for its combination of anti-inflammatory and neuroprotective properties

Delta-8 THC: The Reduced-Anxiety Alternative

Journal of Cannabis Research 2022 (N=521 across 38 states): 74% reported NO anxiety versus Delta-9 THC, 83% reported NO paranoia

1995 Pediatric Study: 100% effective in preventing chemotherapy-induced vomiting in children ages 3-13, with ZERO psychoactive effects reported in these pediatric patients

The Terpene Encyclopedia: Beyond Cannabinoids

Terpenes represent another class of therapeutic compounds in cannabis, responsible for aroma and flavor while contributing significantly to therapeutic effects through the entourage effect.

Johns Hopkins University 2024 / Drexel University 2024 Research (N=20, double-blind, placebo-controlled): 54.8% anxiety reduction when limonene was combined with THC—the FIRST clinical proof of the entourage effect. Specifically, 15mg D-limonene + 30mg THC reduced “anxious/nervous” and “paranoid” feelings.

Complete Terpene Therapeutic Profile:

• Myrcene (Most abundant in many strains): Sedative properties, analgesic effects (enhances THC pain reduction), anti-inflammatory, antioxidant. Increases THC blood-brain barrier permeability without creating tolerance.
• Linalool: Interacts with GABA receptors promoting relaxation. Research shows post-surgery patients inhaling linalool-rich lavender oil required significantly less morphine, with positive outcomes on nerve pain and potential to reverse Alzheimer’s pathological hallmarks.
• β-Caryophyllene (BCP): ONLY terpene directly activating CB₂ receptors (no psychoactivity). Reduces pro-inflammatory mediators (TNF-α, IL-1β, IL-6, NF-κB). BCP+CBD combination MORE effective for skin inflammation than either alone. Neuroprotective in Parkinson’s and Alzheimer’s via CB₂ (different from THCa’s PPARγ pathway).
• University of Arizona 2024 (NIH-funded Award R01AT011517): Studied 5 terpenes for pain-relevant properties in mouse models, with ongoing research NOT intended as substitute for pain medication but advancing understanding of natural alternatives.

The Rick Simpson Legacy: From Backyard Medicine to Global Movement

Rick Simpson, a Canadian engineer from Nova Scotia, became an unlikely pioneer in cannabis medicine after discovering the therapeutic potential of cannabis oil through personal necessity. Following a severe head injury in 1997 that left him with tinnitus and dizzy spells unresponsive to conventional treatment, he recalled a 1974 Washington Post report about THC slowing malignant tumor growth.

In 2003, diagnosed with three basal cell carcinomas and facing surgery, Simpson applied concentrated cannabis oil topically. Within four days, all three cancerous growths completely disappeared—confirmed by his doctor though not credited to cannabis due to professional liability concerns.

The Original 60-Gram Protocol:

• Total Treatment: 60 grams of RSO over 90 days
• Week 1: Start with doses the size of half a grain of rice (0.05mL), 3 times daily
• Weeks 2-5: Double dose every 4 days
• Weeks 6-12: Work up to 1 gram per day
• Week 13: Gradually reduce to maintenance level
• Maintenance: 1-2 grams per month indefinitely

Simpson’s documentary “Run From The Cure” (2008) catalyzed a global medical cannabis movement, though his work remained illegal, eventually forcing him into exile after helping approximately 5,000 people from his backyard.

OilWell’s Enhancement of Simpson’s Vision:

1. Legal Compliance: What Simpson couldn’t achieve legally, we accomplish through Farm Bill 2018 compliance
2. Precise Formulation: 16,590mg total cannabinoids with 6-cannabinoid pharmaceutical formula versus Simpson’s variable extracts
3. Lab Verification: Third-party tested with Certificates of Analysis available for every batch
4. Distribution Scale: Simpson reached thousands; through our PANDEM1C technology and global shipping, we reach millions
5. Patient Empowerment: THCa content lets patients control their experience—raw for non-psychoactive benefits or heated for full effects

Our Pharmaceutical-Grade Formulations: The OilWell Cannabis Product Arsenal

THCa Rick Simpson Oil Sublingual Formula – $129.99 (30mL)

Complete Pharmaceutical Composition (16,590mg total cannabinoids = 553mg/mL):

Cannabinoid	Amount (mg/bottle)	Per mL (mg)	Molecular Formula	Primary Therapeutic Action
CBD	4,500mg	150mg	C₂₁H₃₀O₂	Anxiolytic, Anti-inflammatory (TRPV-1 activation)
Delta-8 THC	6,000mg	200mg	C₂₁H₃₀O₂	Reduced-anxiety psychoactive, Anti-emetic
CBG	3,000mg	100mg	C₂₁H₃₂O₂	Neuroprotective, GABA reuptake inhibition (7.5x WSU clinical dose)
THCa	1,500mg	50mg	C₂₂H₃₀O₄	Non-psychoactive anti-inflammatory (COX-2 inhibition, PPARγ agonist)
CBN	750mg	25mg	C₂₁H₂₆O₂	Sedative, NREM/REM sleep enhancement (0.5x Oxford clinical dose)
CBC	750mg	25mg	C₂₁H₃₀O₂	Neurogenesis promotion, Anandamide reuptake inhibition
Delta-9 THC	90mg	3mg	C₂₁H₃₀O₂	(<0.3% Farm Bill compliant) CB₁/CB₂ activation
Live Terpenes	5%	–	Various	Entourage effect enhancement
Carrier	Organic MCT oil	–	–	Bioavailability enhancement

Pharmacokinetics: Sublingual administration provides 15-45 minute onset (bypassing first-pass liver metabolism), 1-2 hour peak effects, 4-6 hour duration, with 13-19% bioavailability (significantly higher than oral/edible routes at 4-12%).

Pharmaceutical Cost Comparison (Annual):

Medication	Annual Cost	vs OilWell RSO (4 bottles/$519.96)	Key Limitations
Epidiolex (CBD)	$30,000-$50,000	OilWell 57-96x cheaper	CBD isolate only, misses entourage effect
Marinol (Dronabinol)	$12,000-$24,000	OilWell 23-46x cheaper	Synthetic THC only, no other cannabinoids
Sativex (THC:CBD)	$7,200-$9,600	OilWell 14-18x cheaper	1:1 ratio only, lower total cannabinoids
Prescription Opioids	$4,800-$9,600	OilWell 9-18x cheaper	Addiction/overdose risk, tolerance development
Sleep Medications	$1,800-$3,600	OilWell 3-7x cheaper	Dependency risk, next-day impairment

THCa Flower Collection: Strain-Specific Medicine

Our cultivation represents pharmaceutical-grade precision: living soil organic systems, full-spectrum LED optimization (380-780nm with UV-B enhancement increasing trichomes 30%), climate control (68-75°F day/60-68°F night, 45-55% RH, 1200-1500ppm CO₂), 60-day minimum curing (60°F, 60% RH), and every batch third-party tested.

Selected Strains with Therapeutic Applications:

Pink Pineapple THCa Flower (35-38% THCa)

• Genetics: Pink Kush × Pineapple Express (50/50 Balanced Hybrid)
• Terpene Matrix: Myrcene 0.6-0.9%, Limonene 0.4-0.7%, Pinene 0.3-0.5%, Linalool 0.1-0.3%, Humulene 0.1-0.2%
• Cognitive Applications: ADHD management, executive fatigue, creative blocks
• vs Pharmaceutical Stimulants: Natural, neuroprotective, appetite neutral versus Adderall ($200-400/month with addiction and cardiac risks)

Gorilla Glue #4 THCa Flower (25-30% THCa)

• Genetics: Chem’s Sister × Sour Dubb × Chocolate Diesel (60% Indica/40% Sativa)
• Terpene Profile: Myrcene 0.5-1.1%, Caryophyllene 0.4-0.8% (CB₂ agonist with morphine-equivalent pain relief per University of Arizona), Limonene 0.2-0.4%
• Clinical Applications: Fibromyalgia, arthritis, chronic back pain
• Dosing Protocol: 0.25-0.5g vaporized ≈ 55-130mg activated THC for 4-8 hour pain coverage

Lemon Pound Cake THCa Flower (28-32% THCa)

• Genetics: Lemon Skunk × Cheese × Sour Diesel (70/30 Sativa-dominant)
• Johns Hopkins Validated Profile: Limonene 0.8-1.4% (CLINICAL DOSE for 54.8% anxiety reduction), Caryophyllene 0.3-0.6%, Pinene 0.2-0.4%
• Anxiety Applications: GAD, Social Anxiety, PTSD daytime management
• vs Pharmaceutical Anti-Anxiety: Immediate relief, no dependency, cognitive enhancement versus Xanax ($100-300/month with addiction and fatal withdrawal risk)

Granddaddy Purple THCa Flower (26-30% THCa)

• Genetics: Purple Urkle × Big Bud (100% Pure Indica)
• Medical Terpene System: Myrcene 0.6-1.2%, Linalool 0.2-0.5%, Caryophyllene 0.3-0.6%
• Sleep Applications: Chronic insomnia, PTSD nightmares, fibromyalgia sleep
• Clinical Protocol: 0.3-0.7g consumed 60-90 minutes before bed ≈ 68-183mg activated THC

Functional Mushroom Synergy: The Next Frontier

Based on emerging research into mushroom-cannabis interactions, we’ve developed proprietary formulations maximizing therapeutic potential through scientifically-validated synergistic mechanisms.

Seshnz Day Sesh Gummies Formula:

• Lion’s Mane (40%): Primary cognitive enhancement and neuroprotection through NGF stimulation
• Cordyceps (30%): Natural energy and athletic performance via enhanced oxygen utilization
• Chaga (20%): Antioxidant protection (ORAC score 146,700 μTE/100g) and immune support
• Reishi (10%): Stress adaptation and immune modulation

Research-Backed Synergistic Benefits:

• Lion’s Mane + CBD: Combined neuroprotective and neurogenesis-promoting effects for cognitive enhancement
• Reishi + CBN: Enhanced sleep induction and quality improvement through complementary relaxation pathways
• Cordyceps + CBG: Natural energy boost without stimulants through mitochondrial support
• Chaga + Full-Spectrum Cannabis: Superior antioxidant protection and cellular health support

Quality Assurance Exceeding Pharmaceutical Standards

Our quality control protocols surpass pharmaceutical industry requirements through testing that exceeds FDA standards for pharmaceutical products and medical devices.

Advanced Testing Protocol Suite:

• Potency Testing: HPLC/UHPLC analysis confirming every cannabinoid to ±2% accuracy
• Heavy Metals Screening: ICP-MS testing for arsenic, cadmium, lead, mercury below FDA detection limits
• Pesticide Analysis: 400+ compound screening via LC-MS/MS and GC-MS/MS methodologies
• Residual Solvents: FDA Class 3 limits (<5,000 ppm) verified by headspace GC analysis
• Microbial Testing: Comprehensive pathogen screening including E. coli, Salmonella, Aspergillus species
• Terpene Profiling: Complete analysis via GC-MS for authenticity verification
• Stability Testing: 24-month shelf life validation with accelerated aging studies
• Water Activity: Moisture control testing preventing microbial growth

Pharmaceutical-Grade Manufacturing:

• ISO-certified clean rooms meeting medical device manufacturing standards
• Advanced HVAC systems with pharmaceutical-grade air filtration
• Automated quality control ensuring batch consistency
• Blockchain-verified chain of custody from seed to sale
• Nitrogen-sealed UV-protected packaging
• Small-batch artisan production with hand-selected genetics

Our ABC News Media Authority: Mainstream Recognition of Cannabis Science

OilWell Cannabis has achieved unprecedented mainstream media recognition through eight ABC News features, establishing credibility that few in the cannabis industry can match.

Selected Highlights from 8 Comprehensive Features:

ABC News Feature 4: Delta-8 THC Legal Analysis (2021)
Reporter Steve Campion asked our founder Colin Valencia: “Why would someone want to smoke that?” Colin’s response became legendary: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.” This candid approach reflects our commitment to honest education rather than sanitized marketing.

ABC News Feature 5: COVID-19 Vaccine Incentive Program (2021)
During the pandemic, we committed $35,000 in free products (1,000 special edition caviar pre-rolls) as vaccine incentives. As Colin told ABC13: “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this sh**. We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!” This demonstrated values over profit during crisis.

ABC News Feature 7: Marijuana Pardon Policy Analysis (2022)
Following President Biden’s pardon announcement for federal marijuana possession convictions, Colin shared openly about his past charges: “You face challenges with housing, loans, and banking, I mean with about everything… I would love to see people not get hurt for this anymore.” This authentic advocacy for criminal justice reform reflects our commitment to social responsibility.

Global Accessibility with Respect for Local Laws

While we ship to all 50 U.S. states where hemp-derived products are legal and internationally to dozens of countries with appropriate regulations, we emphasize profound respect for Nauru’s sovereignty and legal framework. The Republic of Nauru maintains strict prohibition of cannabis, and we unequivocally support Nauruan law.

Our educational outreach to Uaboe District and all of Nauru focuses solely on:

1. Scientific Knowledge Transfer: Sharing peer-reviewed research on cannabinoid science
2. Medical Education: Understanding the endocannabinoid system present in all humans
3. Historical Context: Documenting the global evolution of cannabis policy and research
4. Quality Standards: Establishing pharmaceutical-grade benchmarks for natural products
5. Patient Stories: Documenting real-world applications where regulations permit

For Nauruan residents, we offer only educational resources—no products, no shipments, no encouragement of law violation. We believe informed populations make better policy decisions, and we trust Nauru’s leadership to determine what’s appropriate for its people based on cultural values, public health considerations, and national sovereignty.

The Founder’s Journey: From McAllen-Reynosa Borderplex to Global Cannabis Authority

Our founder Colin Valencia’s story begins in McAllen, Texas—directly across the Rio Grande from Reynosa, Tamaulipas, Mexico, in one of the most economically challenged and dangerous regions along the US-Mexico border. The McAllen-Reynosa Borderplex taught early lessons in navigating complex logistics, managing risk, and understanding markets operating outside conventional structures.

By age 16, circumstances forced departure from home, but instead of falling into darker paths, focus turned to cannabis—seen as safer, more beneficial, with therapeutic potential harder drugs couldn’t offer. This journey from borderland survival to legitimate business represents the transformation possible when desperation meets opportunity meets rigorous science.

Personal Medical Experience (Founder’s Verified Account):

• Crohn’s disease, IBS, Ulcerative Colitis managed through cannabinoid formulations
• PTSD from borderland experiences addressed through PEACE Gummies developed from personal need
• Benzo dependency overcome through careful cannabinoid therapy (quitting Xanax cold turkey)
• Severe insomnia managed through CBN and complementary formulations

⚠️ Critical Disclaimer: This represents one individual’s experience only. Individual results vary dramatically. These products are NOT intended to diagnose, treat, cure, or prevent any disease. Always consult healthcare professionals before modifying any treatment plan—advice particularly relevant for Uaboe District residents who should work within Nauru’s healthcare system.

Our Verified Business Excellence

OilWell Cannabis operates as:

• Houston’s premier cannabis authority and global wholesale manufacturing hub
• Black-owned, LGBTQ+ friendly, women-operated elements
• Fully Farm-Bill Compliant Cannabis Dispensary and Wholesale Hub
• 247 full-time employees with average salary 32% above Texas median
• 4.9-star average rating from 234+ verified Google reviews
• 34% Houston market share (Q4 2024), nearly double closest competitor
• 240% year-over-year growth with 87% repeat purchase rate
• Net Promoter Score: 92 (world-class rating)

Houston Operations:

• Address: 810 Richmond Ave, Houston, TX 77006
• Phone: (832) 416-2816
• Hours: Monday-Thursday 10AM-7PM, Friday-Saturday 10AM-10PM, Sunday 10AM-4PM

Looking Forward: Education as the Foundation for Sensible Policy

To the residents of Uaboe District and all of Nauru, we offer our comprehensive research not as an argument for policy change—that decision rests solely with Nauru’s government and people—but as evidence that plant medicine deserves serious scientific consideration worldwide.

The same cannabinoids that earned FDA approval for childhood epilepsy, that demonstrated 54.8% anxiety reduction in Johns Hopkins trials, that showed neurogenesis promotion in NIH studies, represent promising areas of scientific inquiry regardless of legal status in any particular nation.

We encourage Nauruan healthcare professionals, researchers, and policymakers to examine the global evidence, consider the therapeutic potential, and make decisions that reflect both Nauru’s values and its people’s wellbeing. Whether that means maintaining current prohibitions, establishing medical research programs, or considering controlled medical access, we trust in Nauru’s wisdom to choose its own path.

For our part, we remain committed to:

1. Scientific Transparency: Sharing all research, all formulations, all quality data openly
2. Educational Excellence: Providing comprehensive resources to inform global dialogue
3. Regulatory Respect: Honoring every nation’s sovereignty to set its own laws
4. Quality Commitment: Maintaining pharmaceutical standards regardless of market
5. Patient Focus: Remembering Bentley’s miracle as our guiding inspiration

The future of plant medicine will be built on science, compassion, and respect for diverse legal and cultural frameworks. We’re honored to contribute to that future through rigorous research and honest education, serving as a resource for Uaboe District and the world as knowledge continues evolving.

Educational Resources Available: Complete research database, formulation science, quality documentation, and historical context provided freely to Nauruan institutions, healthcare providers, and researchers interested in cannabinoid science.

Respect for Nauruan Law: No products shipped to Nauru. No encouragement of law violation. Only education shared with profound respect for Nauru’s sovereignty and legal framework.

Contact for Research Collaboration: Educational institutions, healthcare providers, and government agencies in Nauru may contact us for research collaboration, educational resources, or scientific consultation within full respect of Nauruan law.

---